Development, validation, and initial results of the Angioedema Activity Score

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 9, 2013, Pages 1185-1192

  Weller, K ^a   Groffik, A ^b   Magerl, M ^a   Tohme, N ^a   Martus, P ^c   Krause, K ^a   Metz, M ^a   Staubach, P ^b   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

activity; angioedema; hereditary; urticaria; validation

Indexed keywords

ADULT; AGED; ANGIOEDEMA ACTIVITY SCORE; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FACE VALIDITY; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; RELIABILITY; SCORING SYSTEM; VALIDATION STUDY;

ACTIVITY; ANGIOEDEMA; HEREDITARY; URTICARIA; VALIDATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84884976406     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12209     Document Type: Article

References (22)

1. Banerji A, Sheffer AL,. The spectrum of chronic angioedema. Allergy Asthma Proc 2009; 30: 11-16.
2. Maurer M, Bader M, Bas M, Bossi F, Cicardi M, Cugno M, et al. New topics in bradykinin research. Allergy 2011; 66: 1397-1406.
3. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 2011; 66: 317-330.
4. Maurer M, Magerl M,. Hereditary angioedema: an update on available therapeutic options. J Dtsch Dermatol Ges 2010; 8: 663-672.
5. Zanichelli A, Vacchini R, Badini M, Penna V, Cicardi M,. Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients. Allergy 2011; 66: 192-196.
6. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012; 67: 147-157.
7. Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development and construct validation of the angioedema quality of life questionnaire (AE-QoL). Allergy 2012; 67: 1289-1298.
8. Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010; 65: 290-295.
9. Kocaturk E, Weller K, Martus P, Aktas S, Kavala M, Sarigul S, et al. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. Acta Derm Venereol 2012; 92: 419-425.
10. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-1078.
11. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24 (Suppl 2): 17-22.
12. Budzynski J, Pulkowski G, Suppan K, Fabisiak J, Majer M, Klopocka M, et al. Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey. Health Qual Life Outcomes 2011; 9: 77.
13. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004; 113: 663-668.
14. Yarlas AS, White MK, Yang M, Saris-Baglama RN, Bech PG, Christensen T,. Measuring the health status burden in hemodialysis patients using the SF-36(R) health survey. Qual Life Res 2011; 20: 383-389.
15. Allen MH, Daniel DG, Revicki DA, Canuso CM, Turkoz I, Fu DJ, et al. Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale. Innov Clin Neurosci 2012; 9: 15-24.
16. Juniper EF,. Quality of life questionnaires: does statistically significant = clinically important? J Allergy Clin Immunol 1998; 102: 16-17.
17. Norman GR, Sloan JA, Wyrwich KW,. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
18. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ,. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012; 26: 236-241.
19. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M,. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777-780.
20. Weller K, Church MK, Kalogeromitros D, Krause K, Magerl M, Metz M, et al. Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment. Arch Dermatol 2011; 147: 1221-1223.
21. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154: 294-298.
22. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.